C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2011
06/29/2011	EP1969112B1 Cleaning agent comprising complexes with bleach catalytic activity
06/29/2011	EP1928875B1 2-amino-7,8-dihydro-6H-pyrido(4,3-d)pyrimidin-5-ones, process for their preparation and pharmaceutical compositions containing the same
06/29/2011	EP1907394B1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
06/29/2011	EP1888585B1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
06/29/2011	EP1846407B1 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitor of renin for the treatment of hypertension.
06/29/2011	EP1767536B1 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
06/29/2011	CN1834090B Benzimidazole compounds, its preparation and uses
06/29/2011	CN102112476A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2011	CN102112475A Imidazopyridine and related analogs as sirtuin modulators
06/29/2011	CN102108082A Industrialized semisynthesis of medicine-vincamine for treating cerebral ischemia
06/29/2011	CN101027301B Fused ring azadecalin glucocorticoid receptor modulators
06/28/2011	US7968752 Hydrolytically-resistant boron-containing therapeutics and methods of use
06/28/2011	US7968718 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
06/28/2011	US7968716 Caspase inhibitors and uses thereof
06/28/2011	US7968712 Process for the resolution of zopiclone and intermediate compounds
06/28/2011	US7968664 Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
06/28/2011	US7968566 Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
06/28/2011	US7968563 Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
06/28/2011	US7968562 an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine; fatty acids such as oleic acid, isostearic acid; hydrophobic, aprotic caprylic/capric triglyceride miscible with fatty acid; actinic keratosis, postsurgical scars, warts, atopic dermatitis
06/28/2011	US7968557 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs
06/28/2011	US7968553 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors
06/28/2011	US7968545 Compositions useful as inhibitors of voltage-gated ion channels
06/28/2011	US7968535 Antidiabetic agents; neurodegenerative disorders; mixture with immunosuppresants
06/28/2011	US7968215 OLED device with cyclobutene electron injection materials
06/28/2011	CA2602248C Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
06/28/2011	CA2512608C (2-carboxamido)(3-amino) thiophene compounds
06/28/2011	CA2496241C 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/28/2011	CA2467672C Chemokine receptor antagonists and methods of use therefor
06/28/2011	CA2383753C Process for production of naphthyridine-3-carboxylic acid derivatives
06/23/2011	WO2011075699A2 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
06/23/2011	WO2011075628A1 Heterocyclic compounds and their uses
06/23/2011	WO2011075613A1 Azaindole derivatives, their preparation and their therapeutic application
06/23/2011	WO2011075607A1 Novel inhibitors of hepatitis c virus replication
06/23/2011	WO2011075591A1 Anti parasitic dihydroazole compounds and compositions comprising same
06/23/2011	WO2011075487A1 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders
06/23/2011	WO2011074658A1 Novel anti-platelet agent
06/23/2011	WO2011074017A1 A novel process for the preparation of paliperidone
06/23/2011	WO2011073997A2 Process for preparing paliperidone and pharmaceutically acceptable salts thereof
06/23/2011	WO2011073907A1 A polymorph form of nevirapine and its preparation
06/23/2011	WO2011073371A1 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)
06/23/2011	WO2011073316A1 4-aryl-butane-1,3-diamides
06/23/2011	WO2011073277A1 PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS Kv1.3 MODULATORS
06/23/2011	WO2011073269A1 Piperidine aryl sulfonamide derivatives as kv1.3 modulators
06/23/2011	WO2011073263A1 1, 7 - diazacarbazoles and their use in the treatment of cancer
06/23/2011	WO2011073172A1 Ethynyl derivatives
06/23/2011	WO2011073165A1 New phenylhydrazone derivatives and their use as pharmaceuticals
06/23/2011	WO2011073119A1 Mk2 inhibitors
06/23/2011	WO2011073118A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
06/23/2011	WO2011073117A1 Azaindole glucokinase activators
06/23/2011	WO2011073092A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/23/2011	WO2011072697A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2011072696A1 2-arylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2011072695A1 Phenylimidazole derivatives comprising an ethynylene linker as pde10a enzyme inhibitors
06/23/2011	WO2011072694A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2010066832A8 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer
06/23/2011	US20110152562 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING a-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
06/23/2011	US20110152528 Method For Producing 3,7-Diaza-Bicyclo[3.3.1] Nonane Compounds
06/23/2011	US20110152526 Methoxatin derivatives
06/23/2011	US20110152337 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2011	US20110152313 Synthesis of ageladine a and analogs thereof
06/23/2011	US20110152312 Antiparisitic dihydroazole compounds and compositions comprising same
06/23/2011	US20110152311 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
06/23/2011	US20110152310 Tricyclic triazole compounds that modulate hsp90 activity
06/23/2011	US20110152309 Pharmaceutical, food or beverage having inhibitory activity on serotonin transporter
06/23/2011	US20110152308 Aza-ring fused indole and indoline derivatives
06/23/2011	US20110152306 Aza-bridged ring-fused indoles and indolines
06/23/2011	US20110152304 Spiroazaindoles
06/23/2011	US20110152301 Compounds that Inhibit HIV Particle Formation
06/23/2011	US20110152296 Heterocyclic compounds and their uses
06/23/2011	US20110152282 Hedgehog pathway modulators
06/23/2011	US20110152278 Synthesis and anti-proliferative effect of benzimidazole derivatives
06/23/2011	US20110152277 Heterocyclic compounds and their uses
06/23/2011	US20110152273 Fused heteroaromatic pyrrolidinones
06/23/2011	US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor
06/23/2011	US20110152257 Ethynyl compounds useful for treatment of cns disorders
06/23/2011	US20110152251 Compounds for modulating tlr2
06/23/2011	US20110152243 Novel thienopyrrole compounds
06/23/2011	US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists
06/23/2011	US20110152238 Pharmaceutical compounds
06/23/2011	US20110152237 Chemical Compounds
06/23/2011	US20110152232 Sulfonamide compounds and uses thereof
06/23/2011	US20110151022 Thiotungstate analogues and uses thereof
06/23/2011	US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
06/23/2011	US20110150833 Benzopyrans and analogs as rho kinase inhibitors
06/23/2011	US20110150831 Novel naphthyridine derivatives and the use thereof as kinase inhibitors
06/23/2011	US20110150757 Compounds for inhibiting ksp kinesin activity
06/23/2011	US20110149393 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof
06/23/2011	US20110148292 Organic compound and organic light-emitting device using the same
06/23/2011	US20110147732 Benzofluoranthene derivative and organic electroluminescence element comprising same
06/23/2011	CA2784830A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
06/23/2011	CA2784566A1 Heterocyclic compounds and their uses
06/23/2011	CA2784122A1 Antiparasitic dihydroazole compounds and compositions comprising same
06/23/2011	CA2784010A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
06/23/2011	CA2783728A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
06/23/2011	CA2783726A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	CA2782601A1 Novel antiplatelet agent
06/23/2011	CA2782574A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/23/2011	CA2782361A1 Bridgehead amine ring-fused indoles and indolines useful to treat neurodegenerative and neuropsychiatric disorders
06/23/2011	CA2782213A1 1,7-diazacarbazoles and their use in the treatment of cancer
06/23/2011	CA2782172A1 Azaindole glucokinase activators

1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 646